You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Haploidentical

Showing 51 - 75 of 569
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Donor-recipient ABO Matching on Haploidentical Stem Cell

Completed
  • Hematological Malignancies
  • Haploidentical Stem Cell Transplantation
  • no intervention
  • Hangzhou, Zhejiang, China
  • +1 more
Oct 22, 2021

Transplant-Related Hematologic Malignancy Trial in Atlanta (Sargramostim, Control Arm)

Recruiting
  • Transplant-Related Hematologic Malignancy
  • Atlanta, Georgia
    Northside Hospital
Oct 19, 2022

Refractory Idiopathic Aplastic Anemia, Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation Trial (Allogenic

Not yet recruiting
  • Refractory Idiopathic Aplastic Anemia
  • Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation
  • Allogenic transplantation
  • (no location specified)
Nov 8, 2021

Myelodysplasia, Hematologic Malignancy Trial in Columbus (CliniMACS® TCRaß/CD19 Combined Depletion System)

Recruiting
  • Myelodysplasia
  • Hematologic Malignancy
  • CliniMACS® TCRαβ/CD19 Combined Depletion System
  • Columbus, Ohio
    Nationwide Children's Hospital
Jan 11, 2022

To Evaluate the Efficacy and Safety of Secondary Prophylaxis of CMV Reactivation Trial (Letermovir for secondary prophylaxis)

Not yet recruiting
  • To Evaluate the Efficacy and Safety of Secondary Prophylaxis of CMV Reactivation
  • Letermovir for secondary prophylaxis
  • (no location specified)
Jun 13, 2023

Allogeneic Hematopoietic Stem Cell Transplantation Recipient, Cytomegalovirus, Donor Trial in Columbus (Allogeneic

Recruiting
  • Allogeneic Hematopoietic Stem Cell Transplantation Recipient
  • +3 more
  • Allogeneic Cytomegalovirus-Specific Cytotoxic T lymphocytes
  • Columbus, Ohio
  • +1 more
Apr 20, 2022

The Incidence of Peripheral Blood CMV Activation and Confirmed Clinically Significant CMV Infection Within 24 Weeks After

Not yet recruiting
  • The Incidence of Peripheral Blood CMV Activation and Confirmed Clinically Significant CMV Infection Within 24 Weeks After Transplantation
  • (no location specified)
Jun 13, 2023

Hematologic Disorders Trial in Aurora (Miltenyi CliniMACS® CD34 Reagent System)

Recruiting
  • Hematologic Disorders
  • Miltenyi CliniMACS® CD34 Reagent System
  • Aurora, Colorado
    University of Colorado
Feb 22, 2022

Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, MDS Trial in Houston (CliniMACS)

Not yet recruiting
  • Acute Lymphoblastic Leukemia in Remission
  • +10 more
  • CliniMACS
  • Houston, Texas
  • +1 more
Dec 8, 2022

Hematological Malignancies, Hematopoietic Stem Cell Transplantation Trial in Guangzhou (PBSCs, Cord, BMSCs)

Recruiting
  • Hematological Malignancies
  • Hematopoietic Stem Cell Transplantation
  • PBSCs
  • +2 more
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Mar 13, 2022

Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, MDS Trial in Saint Louis (procedure, drug, other)

Recruiting
  • Acute Myelogenous Leukemia
  • +4 more
  • Stem cell transplantation
  • +3 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Aug 23, 2022

Hematological Malignancy Trial in Detroit (Bortezomib)

Recruiting
  • Hematological Malignancy
  • Detroit, Michigan
    Henry Ford hospital
Dec 23, 2021

Acute Myeloid Leukemia Trial (NK cells, Talazoparib 1 MG [Talzenna])

Not yet recruiting
  • Acute Myeloid Leukemia
  • NK cells
  • Talazoparib 1 MG [Talzenna]
  • (no location specified)
Jan 9, 2023

Severe Aplastic Anemia Trial in Atlanta (Fludarabine, Cyclophosphamide, Total Body Irradiation)

Recruiting
  • Severe Aplastic Anemia
  • Atlanta, Georgia
  • +1 more
Apr 4, 2022

Sickle Cell Disease Trial in United States (CD34 selected T-cell depleted allogeneic SCT)

Active, not recruiting
  • Sickle Cell Disease
  • CD34 selected T-cell depleted allogeneic SCT
  • Los Angeles, California
  • +5 more
Sep 27, 2022

Leukemia, Stem Cell Transplant, Cord Blood Trial in Guangzhou (applying of FLU+CY post-HSCT)

Recruiting
  • Leukemia
  • +2 more
  • applying of FLU+CY post-HSCT
  • Guangzhou, Guangdong, China
    Nanfang Hospital
Nov 23, 2023

Letermovir Prophylaxis for CMV Infection in Haplo-HSCT

Recruiting
  • CMV Infection
  • Hematopoietic Stem Cell Transplantation
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow university
Mar 29, 2023

Ewing Sarcoma, Neuroblastoma, Rhabdomyosarcoma Trial in Milwaukee (Allogeneic HCT, Donor NK Cell Infusion)

Active, not recruiting
  • Ewing Sarcoma
  • +4 more
  • Allogeneic HCT
  • Donor NK Cell Infusion
  • Milwaukee, Wisconsin
  • +1 more
Apr 5, 2022

CMV Trial in Santander (CMV CTLs)

Recruiting
  • CMV
  • CMV CTLs
  • Santander, Spain
    Hospital Marques de Valdecilla
May 5, 2022

Graft Vs Host Disease Trial in New York (Cyclophosphamide, Abatacept, Tacrolimus)

Recruiting
  • Graft Vs Host Disease
  • New York, New York
    NYU Langone Health
Nov 10, 2022

Hematologic Diseases, Graft Failure, Allogeneic Hematopoietic Stem Cell Transplantation Trial (haplo-SCT with PTCy)

Not yet recruiting
  • Hematologic Diseases
  • +2 more
  • haplo-SCT with PTCy
  • (no location specified)
Nov 8, 2021

Acute Myeloid Leukemia Trial in Los Angeles (Haploidentical IL-21-Expanded Natural Killer Cells)

Enrolling by invitation
  • Acute Myeloid Leukemia
  • Haploidentical IL-21-Expanded Natural Killer Cells
  • Los Angeles, California
    Children's Hospital Los Angeles
Nov 1, 2021

Sickle Cell Disease Trial in Chicago (drug, radiation, procedure)

Recruiting
  • Sickle Cell Disease
  • Chicago, Illinois
    University of Illinois at Chicago
Oct 21, 2021

Blood Disease Trial (TCRaß+/CD19+ depleted Hematopoietic stem cell (HSC) graft, CliniMACS® System)

Not yet recruiting
  • Blood Disease
  • TCRαβ+/CD19+ depleted Hematopoietic stem cell (HSC) graft
  • CliniMACS® System
  • (no location specified)
Jan 30, 2023

Hematologic Malignancies Trial in La Jolla (Cyclophosphamide 50 mg/kg IV Days 3 and 4 post transplant)

Suspended
  • Hematologic Malignancies
  • Cyclophosphamide 50 mg/kg IV Days 3 and 4 post transplant
  • La Jolla, California
    UCSD Medical Center
Jul 20, 2022